Large-scale screening programs for eye health
Postponing a doctor’s visit can delay the detection of eye diseases until it’s too late. Many symptoms remain unnoticed until the condition has progressed significantly.
Fast and reliable screening for early disease detection
Diabetic retinopathy (DR) is a sight-threatening complication of diabetes that requires early diagnosis for effective management. Over 93 million people worldwide live with DR, making it a leading cause of vision impairment among the working-age population. With timely diagnosis, DR can be controlled, and severe vision loss can be prevented.
The Challenge - How to ensure early detection of DR
National screening programs for high-risk populations have been introduced in many countries to enable early detection of DR. These programs ensure timely health checks even before vision problems emerge. However, scaling such programs presents challenges:
• Overburdened healthcare systems: Medical eye specialists must analyze hundreds or thousands of eye scans per year.
• High workloads: Managing vast patient volumes creates significant pressure, making implementation difficult.
The Solution - iCare RETCAD
iCare RETCAD is an AI-powered, thoroughly validated software that transforms eye screening. It enables quick, automated, and highly reliable examinations—perfect for large-scale programs. With iCare RETCAD, healthcare providers can:
• Streamline the screening process.
• Reduce pressure on medical specialists.
• Provide actionable insights with instant, detailed patient reports.
Key features
- Precise detection: iCare RETCAD identifies abnormalities through advanced image analysis.
- Clear recommendations: Patients receive tailored guidance for regular checkups or immediate specialist care.
- Unmatched efficiency: AI analysis takes approximately one minute, supporting faster decision-making.
How it works
- Retinal images are captured using a fundus camera.
- iCare RETCAD analyzes the images in approximately one minute.
- An examination report with visual results and recommendations is automatically generated.
Proven results
When detecting referable diabetic retinopathy, iCare RETCAD delivers results you can trust. Its performance, validated across many populations and clinical settings, is comparable to that of human experts, as demonstrated in multiple peer-reviewed studies.
Read more-
Take action today
Revolutionize your screening programs with iCare RETCAD.
Contact us -
Empowering eye health at scale
iCare RETCAD makes population-level screening programs quick, simple, and reliable, ensuring more people receive early care to protect their vision.
